Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
Cines DB, Yarovoi SV, Zaitsev SV, Lebedeva T, Rauova L, Poncz M, Arepally GM, Khandelwal S, Stepanova V, Rux AH, Cuker A, Guo C, Ocariza LM, Travers RJ, Smith SA, Kim H, Morrissey JH, Conway EM. Cines DB, et al. Among authors: zaitsev sv. Blood Adv. 2016 Nov 22;1(1):62-74. doi: 10.1182/bloodadvances.2016000877. eCollection 2016 Nov 29. Blood Adv. 2016. PMID: 29296696 Free PMC article.
Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V, Jayaraman PS, Zaitsev SV, Lebedeva T, Bdeir K, Kershaw R, Holman KR, Parfyonova YV, Semina EV, Beloglazova IB, Tkachuk VA, Cines DB. Stepanova V, et al. Among authors: zaitsev sv. J Biol Chem. 2016 Jul 15;291(29):15029-45. doi: 10.1074/jbc.M115.678490. Epub 2016 May 4. J Biol Chem. 2016. PMID: 27151212 Free PMC article.
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V, Dergilev KV, Holman KR, Parfyonova YV, Tsokolaeva ZI, Teter M, Atochina-Vasserman EN, Volgina A, Zaitsev SV, Lewis SP, Zabozlaev FG, Obraztsova K, Krymskaya VP, Cines DB. Stepanova V, et al. Among authors: zaitsev sv. J Biol Chem. 2017 Dec 15;292(50):20528-20543. doi: 10.1074/jbc.M117.799593. Epub 2017 Sep 27. J Biol Chem. 2017. PMID: 28972182 Free PMC article.
Insulinotropic compounds decrease endothelial cell survival.
Zaitseva II, Berggren PO, Zaitsev SV. Zaitseva II, et al. Among authors: zaitsev sv. Toxicol In Vitro. 2016 Jun;33:1-8. doi: 10.1016/j.tiv.2016.02.004. Epub 2016 Feb 13. Toxicol In Vitro. 2016. PMID: 26883446
Two generations of insulinotropic imidazoline compounds.
Efendic S, Efanov AM, Berggren PO, Zaitsev SV. Efendic S, et al. Among authors: zaitsev sv. Diabetes. 2002 Dec;51 Suppl 3:S448-54. doi: 10.2337/diabetes.51.2007.s448. Diabetes. 2002. PMID: 12475789 Review.
Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat.
Efanov AM, Appelskog IB, Abdel-Halim SM, Khan A, Bränström R, Larsson O, Ostenson CG, Mest HJ, Berggren PO, Efendic S, Zaitsev SV. Efanov AM, et al. Among authors: zaitsev sv. Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E117-24. doi: 10.1152/ajpendo.000031.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 11739091 Free article.
124 results